Physicians' understanding of consent requirements for phase I clinical trials in cognitively impaired or highly vulnerable populations.
We investigated physicians' attitudes about entering patients who cannot give informed consent or who are of a vulnerable population into clinical trials. A survey instrument asked a nationwide sample of practicing physicians about whether ten hypothetical patients could be enrolled in a phase I clinical trials. The impact of demographic variables on the number of scenarios viewed as completely or somewhat acceptable was analyzed via student's T tests or analysis of variance (ANOVA) as applicable. All significant (p
Published In/Presented At
Farber, N. J., Aboff, B. M., DeJoseph, M. R., Castellano, J., Weiner, J., & Boyer, E. G. (2004). Physicians' understanding of consent requirements for phase I clinical trials in cognitively impaired or highly vulnerable populations. Accountability in research, 11(1), 63–78. https://doi.org/10.1080/725289014
Medicine and Health Sciences
Department of Medicine